BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28133294)

  • 21. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
    Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
    Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of ascending colon cancer with unresectable distant metastases treated by systemic chemotherapy].
    Sugimoto K; Tashiro Y; Nagayasu K; Niwa K; Ono S; Ishiyama S; Hata M; Komiyama H; Takahashi M; Yaginuma Y; Kojima Y; Goto M; Tanaka M; Sengoku H; Okuzawa A; Tomiki Y; Sakamoto K
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1167-70. PubMed ID: 20567130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A surgical (right lobectomy) case of liver metastasis of colon cancer after chemotherapy using mFOLFIRI and cetuximab].
    Shimobayashi T; Inatsugi N; Yoshikawa S; Masuda T; Uchida H; Kuge H; Yokotani T; Yamaguchi T; Kawaguchi C; Yamaoka K; Inagaki M; Matsuoka M; Tatsumi K; Saraya T; Otsuji T; Yamochi Y; Yamanishi K; Enomoto Y; Nonomura A; Sho M; Nakajima Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2340-2. PubMed ID: 21224566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of liver metastasis from sigmoid colon cancer treated effectively by second-line chemotherapy].
    Gokita K; Ami K; Matsunaga Y; Fujiya K; Ohshima N; Amagasa H; Ganno H; Imai K; Fukuda A; Nagahama T; Ando M; Akita H; Tei S; Okada Y; Arai K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1761-3. PubMed ID: 25731321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of unresectable advanced rectal cancer with liver metastases by hemostasis re-irradiation of the rectal cancer and palliative low-dose whole-liver radiation therapy: a case report.
    Yasuda T; Tanaka O; Hayashi S; Nakahata Y; Yasuda Y; Omatsu T; Obora A; Kojima T; Matsuo M; Yagi N
    Clin J Gastroenterol; 2020 Feb; 13(1):11-16. PubMed ID: 31321737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Cecal Cancer with Liver and Lung Metastases That Maintained Long Stable Disease by TFTD and Bevacizumab Chemotherapy].
    Takeuchi M
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1657-1660. PubMed ID: 30449858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of multiple liver metastases from rectal cancer in poor performance status successfully treated with hepatic arterial infusion chemotherapy plus CPT-11].
    Ide Y; Okada K; Ohta H; Maruyama K; Yokouchi H; Kinuta M; Yasumoto T; Murata K
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2059-61. PubMed ID: 18219898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].
    Tomita M; Kuboi K; Kameyama N; Mitsuhashi H; Matsumoto N; Hasegawa Y; Sekimoto Y
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):121-4. PubMed ID: 21368472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study.
    Köhne CH; Poston G; Folprecht G; Ciardiello F; Ronga P; Beier F; Van Cutsem E
    Eur J Surg Oncol; 2016 Oct; 42(10):1540-7. PubMed ID: 27575968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
    Hirose H; Ikeda M; Miyoshi N; Kim HM; Okano M; Uemura M; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Ishii H; Sekimoto M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2545-7. PubMed ID: 21224634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
    Heinemann V; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Stauch M; Scheithauer W; Hielscher J; Scholz M; Müller S; Link H; Niederle N; Rost A; Höffkes HG; Moehler M; Lindig RU; Modest DP; Rossius L; Kirchner T; Jung A; Stintzing S
    Lancet Oncol; 2014 Sep; 15(10):1065-75. PubMed ID: 25088940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of multiple lung and liver metastases from colon cancer treated with clinical benefit by hepatic arterial infusion chemotherapy plus cetuximab mono-therapy after standard chemotherapy failure].
    Osawa G; Yoshimatsu K; Yokomizo H; Otani T; Yano Y; Itagaki H; Matsumoto A; Fujimoto T; Umehara A; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2526-8. PubMed ID: 21224628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Case of Rectal Neuroendocrine Carcinoma with Metachronous Liver Metastasis Treated with Multimodality Therapy].
    Miyamae Y; Shimizu H; Naganuma A; Aiba M; Tanaka T; Ogawa T; Ogawa A; Osamura Y
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):1009-13. PubMed ID: 27539046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
    Huiskens J; van Gulik TM; van Lienden KP; Engelbrecht MR; Meijer GA; van Grieken NC; Schriek J; Keijser A; Mol L; Molenaar IQ; Verhoef C; de Jong KP; Dejong KH; Kazemier G; Ruers TM; de Wilt JH; van Tinteren H; Punt CJ
    BMC Cancer; 2015 May; 15():365. PubMed ID: 25943574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of advanced rectal cancer with lung and bone metastasis that was successfully treated with mFOLFOX6+bevacizumab].
    Masuda T; Uetake H; Yamauchi S; Okazaki S; Matsuyama T; Ishiguro M; Ishikawa T; Kobayashi H; Iida S; Higuchi T; Sugihara K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2264-6. PubMed ID: 23268044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case report of two colorectal cancer patients with liver metastasis showing favorable response to fluorouracil and l-leucovorin therapy].
    Katsumata K; Ichimiya H; Wakana Y; Okada K; Kato K; Aoki T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):623-5. PubMed ID: 15114713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.
    Uehara K; Ishiguro S; Hiramatsu K; Nishio H; Takeuchi E; Takahari D; Yoshioka Y; Takahashi Y; Ebata T; Yoshimura K; Muro K; Nagino M
    Jpn J Clin Oncol; 2011 Oct; 41(10):1229-32. PubMed ID: 21840871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of advanced rectal cancer treated with leucovorin, fluorouracil, and oxaliplatin plus panitumumab preoperative chemotherapy].
    Takahashi H; Ishikawa T; Iwata N; Baba H; Masuda T; Okazaki S; Matsuyama T; Ishiguro M; Kobayashi H; Iida S; Uetake H; Sugihara K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1953-5. PubMed ID: 24393977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of sigmoid colon cancer with synchronous multiple liver and lung metastases, who survived 25-month after combination of chemotherapy and metastasectomy].
    Kikuchi A; Ishikawa T; Uetake H; Tanaka S; Arii S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2539-41. PubMed ID: 21224632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A Case of Stage IV Rectal Cancer Achieving Long-Term Stable Disease Treated with Chemotherapy and Residual Tumor Resection].
    Yoshimatsu K; Satake M; Sano M; Kodera A; Imaizumi R; Ito Y; Koike T; Yokomizo H; Yano Y; Okayama S; Yamada Y; Asaka S; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1527-1529. PubMed ID: 30382067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.